PROSPECTUS SUPPLEMENT NO. 5

Filed Pursuant to Rule 424(b)(3)

Registration No. 333-123781

 

PROSPECTUS SUPPLEMENT NO. 5 DATED JANUARY 20, 2006

(TO PROSPECTUS DATED JUNE 20, 2005)

 

PANACOS PHARMACEUTICALS, INC.

14,717,497 SHARES OF COMMON STOCK

 

This Prospectus Supplement No. 5 supplements and amends the Prospectus dated June 20, 2005 (the “Prospectus”), as supplemented by Prospectus Supplement No. 1, dated August 25, 2005 (“Supplement No. 1”), Prospectus Supplement No. 2, dated August 31, 2005 (“Supplement No. 2”), Prospectus Supplement No. 3, dated September 8, 2005 (“Supplement No. 3”), and Prospectus Supplement No. 4, dated November 10, 2005 (“Supplement No. 4”), relating to the resale from time to time by holders of our shares of common stock. Such information has been obtained from the selling stockholders. This prospectus supplement should be read in conjunction with the Prospectus and Supplements No. 1, 2, 3 and 4, which are to be delivered with this prospectus supplement.

 

Our common stock is quoted on The Nasdaq National Market under the symbol “PANC.” The last reported sale price of our common stock on January 19, 2006 was $8.60 per share.

 

See “Risk Factors” beginning on page 6 of the Prospectus to read about factors you should consider before buying our common stock.

 

Neither the Securities and Exchange Commission, any state securities commission nor any other regulatory authority, has approved or disapproved the securities nor have any of the foregoing authorities passed upon or endorsed the merits of this offering or the accuracy or adequacy of this Prospectus Supplement or the Prospectus or the documents incorporated by reference therein. Any representation to the contrary is a criminal offense.

The information appearing in the table below, as of the date hereof, supplements and amends the information in the table appearing under the heading “Selling Stockholders” in the Prospectus, and, where the name of a selling stockholder identified in the table below also appears in the table in the Prospectus, the information set forth in the table below regarding that selling stockholder supercedes the information in the Prospectus:

 

     Shares Beneficially
Owned Before
Offering(1)
     Shares Being
Offered
    Shares Beneficially
Owned After
Offering(2)
  
     Number
    Percent
        Number
    Percent
  

Selling Stockholder

                            

W.H.I. Growth Fund Q.P., L.P. (3)

    140,625    ** %   140,625    —      ** %

Fenton Family Foundation

    4,130    ** %   4,130    —      ** %

 

** Less than 1%

 

(1) Percentages prior to the offering are based on 49,911,657 shares of common stock (adjusting for our March 14, 2005 1-for-10 reverse stock split) that were issued and outstanding as of December 31, 2005. We deem shares of common stock that may be acquired by an individual or group within 60 days of December 31, 2005 pursuant to the exercise of options or warrants to be outstanding for the purpose of computing the percentage ownership of such individual or group, but such shares are not deemed to be outstanding for the purpose of computing the percentage ownership of any other individual or entity shown in the table.

 

(2) We do not know when or in what amounts the selling stockholders may offer for sale the shares of common stock pursuant to this offering. The selling stockholders may choose not to sell any of the shares offered by this prospectus. Because the selling stockholders may offer all or some of the shares of common stock pursuant to this offering, and because there are currently no agreements, arrangements or undertakings with respect to the sale of any of the shares of common stock, we cannot estimate the number of shares of common stock that the selling stockholders will hold after completion of the offering. For purposes of this table, we have assumed that the selling stockholders will have sold all of the shares listed under the column “Shares Being Offered” in this prospectus upon the completion of the offering.

 

(3) Jack Polsky is the President and Michael Resnick is the Executive Vice President of William Harris Investors, Inc., which is the General Partner of W.H.I. Growth Fund Q.P., L.P.

 

The selling stockholders identified above may have sold, transferred or otherwise disposed of all or a portion of our common stock since the date on which they provided the information about their common stock in transactions exempt from the registration requirements of the Securities Act.